Pages that link to "Q28295525"
Jump to navigation
Jump to search
The following pages link to Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management (Q28295525):
Displaying 19 items.
- European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (Q21260332) (← links)
- Bupropion for Attention Deficit Hyperactivity Disorder (ADHD) in adults (Q24234795) (← links)
- Prevalence of Adult Attention Deficit Hyperactivity Disorder (Adult ADHD): Tabriz (Q34990471) (← links)
- Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial (Q35610253) (← links)
- The FIBRO System: A Rapid Strategy for Assessment and Management of Fibromyalgia Syndrome (Q36059504) (← links)
- Assessment of physician practices in adult attention-deficit/hyperactivity disorder (Q36419742) (← links)
- Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder (Q37354631) (← links)
- A symptom-based approach to pharmacologic management of fibromyalgia (Q37428736) (← links)
- Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder. (Q37643681) (← links)
- The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents (Q38023225) (← links)
- The safety and efficacy of methylphenidate and dexmethylphenidate in adults with attention deficit/hyperactivity disorder. (Q38122148) (← links)
- Comorbidities in adult attention-deficit/hyperactivity disorder: a practical guide to diagnosis in primary care (Q38258102) (← links)
- Aiming for remission in adults with attention-deficit/hyperactivity disorder: The primary care goal (Q38348042) (← links)
- Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder (Q38463350) (← links)
- Neurocognitive psychotherapy for adult attention deficit hyperactive disorder (Q41276580) (← links)
- Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study (Q42339253) (← links)
- Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. (Q43075919) (← links)
- Psychostimulants and forced swim stress interaction: how activation of the hypothalamic-pituitary-adrenal axis and stress-induced hyperglycemia are affected. (Q50202626) (← links)
- Anxiety in college students With ADHD: relationship to cognitive functioning (Q50559895) (← links)